MCT4 activators are a class of chemicals that either directly stimulate the activity of MCT4 or impact the biochemical pathways that modulate its function. Activation of AMP-activated protein kinase (AMPK) by chemicals like A-769662 and Metformin can stimulate MCT4 transcription and surface expression, rendering cells more proficient in lactate and pyruvate transport. Another avenue of activation comes through hormone modulation. Dexamethasone, a glucocorticoid, upregulates MCT4 via the glucocorticoid receptor. Rosiglitazone, a PPARγ agonist, also promotes MCT4 expression, widening the metabolic capacities of cells. Hypoxia or its mimetics like Cobalt Chloride can also contribute to MCT4 activation by stabilizing HIF-1α, a transcription factor crucial for the expression of genes involved in cellular response to low oxygen levels.
Calcium signaling also influences MCT4 activity; Nifedipine, a calcium channel blocker, can affect this. The metabolic substrate, sodium pyruvate, directly impacts the MCT4 cycle, essentially increasing the need for its activity. Isoproterenol, a β-adrenergic agonist, impacts cAMP levels and can indirectly upregulate MCT4. Some chemicals like LY294002 and 17-AAG influence MCT4 by affecting related pathways. LY294002 inhibits PI3K, leading to metabolic shifts that require MCT4 activation. 17-AAG, an HSP90 inhibitor, modulates cellular stress responses, providing another level of control over MCT4 function.
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
A-769662 | 844499-71-4 | sc-203790 sc-203790A sc-203790B sc-203790C sc-203790D | 10 mg 50 mg 100 mg 500 mg 1 g | $184.00 $741.00 $1076.00 $3417.00 $5304.00 | 23 | |
Activates AMPK, which enhances MCT4 transcription and surface expression. | ||||||
Dexamethasone | 50-02-2 | sc-29059 sc-29059B sc-29059A | 100 mg 1 g 5 g | $91.00 $139.00 $374.00 | 36 | |
Glucocorticoid that can upregulate MCT4 via the glucocorticoid receptor. | ||||||
Rosiglitazone | 122320-73-4 | sc-202795 sc-202795A sc-202795C sc-202795D sc-202795B | 25 mg 100 mg 500 mg 1 g 5 g | $120.00 $326.00 $634.00 $947.00 $1259.00 | 38 | |
PPARγ agonist that induces MCT4 expression. | ||||||
Cobalt(II) chloride | 7646-79-9 | sc-252623 sc-252623A | 5 g 100 g | $64.00 $176.00 | 7 | |
Hypoxia mimetic that stabilizes HIF-1α, leading to enhanced MCT4 expression. | ||||||
Nifedipine | 21829-25-4 | sc-3589 sc-3589A | 1 g 5 g | $59.00 $173.00 | 15 | |
Calcium channel blocker that modulates calcium signaling, affecting MCT4 activity. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
PI3K inhibitor that shifts metabolic processes, leading to MCT4 activation. | ||||||
17-AAG | 75747-14-7 | sc-200641 sc-200641A | 1 mg 5 mg | $67.00 $156.00 | 16 | |
HSP90 inhibitor that can affect cellular stress responses, indirectly modulating MCT4 activity. | ||||||